Goldman Sachs’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Goldman Sachs’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-85,291	Closed	-$859K	–	6451
2022 Q4	$859K	Hold	85,291	–	–	﹤0.01%	4525
2022 Q3	$844K	Sell	85,291 -6,500	-7%	-$64K	﹤0.01%	4628
2022 Q2	$898K	Buy	91,791 +73,573	+404%	+$721K	﹤0.01%	4693
2022 Q1	$178K	Buy	18,218 +1,200	+7%	+$11.7K	﹤0.01%	5927
2021 Q4	$165K	Hold	17,018	–	–	﹤0.01%	5973
2021 Q3	$166K	Buy	17,018 +100	+0.6%	+$963	﹤0.01%	5784
2021 Q2	$163K	Buy	+16,918	New	+$165K	﹤0.01%	5818

Goldman Sachs's MSAC Position: Q1 2023 in Review

Goldman Sachs sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 85,291 shares — an estimated $859K sold.

Goldman Sachs first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $898K in Q2 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Goldman Sachs reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Goldman Sachs sold 85,291 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $859K.
Goldman Sachs first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Goldman Sachs's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $898K in Q2 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.